在种族和民族多样化患者中尽管普遍进行结直肠癌筛查,基因检测转诊率仍低
该回顾性分析纳入4个学术中心2012至2016年767例结直肠癌患者的肿瘤样本,评估错配修复缺陷检测、遗传评估转诊及胚系检测率。总体92%肿瘤进行了错配修复缺陷检测且无种族差异,但少数族裔患者转诊遗传评估和接受基因检测的比例显著更低。多因素分析显示非裔美国人种族、高龄和医疗中心与未转诊独立相关。
要点
- 767例结直肠癌患者中92%肿瘤进行了错配修复缺陷检测,各人种间无显著差异。
- 非西班牙裔白人遗传评估转诊率21.2%,非裔美国人16.9%,西班牙裔10.9%(P=0.02)。
- 基因检测率非西班牙裔白人10.7%,非裔美国人6.0%,西班牙裔3.1%(P<0.01)。
核心结论
- 尽管结直肠肿瘤分析率相似,少数族裔患者被推荐进行遗传评估或接受林奇综合征胚系检测的可能性更低。
研究设计与样本
- 回顾性分析,纳入4个学术中心2012年至2016年收集的767例结直肠癌患者的肿瘤样本。
- 患者中52%为非西班牙裔白人,26%为非裔美国人,17%为西班牙裔。
主要发现
- 总体92%的结直肠肿瘤进行了错配修复缺陷分析,各人种/民族间无显著差异。
- 遗传评估转诊率:非西班牙裔白人21.2%,非裔美国人16.9%,西班牙裔10.9%(P=0.02)。
- 基因检测率:非西班牙裔白人10.7%,非裔美国人6.0%,西班牙裔3.1%(P<0.01)。
- 多因素分析中,非裔美国人种族、高龄和医疗中心与未转诊遗传评估及未进行基因检测独立相关。
临床怎么用
- 作者认为,改进肿瘤检测后随访的机构实践可能减少少数族裔林奇综合征诊断的障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Guidelines recommend that all colorectal tumors be assessed for mismatch repair deficiency, which could increase identification of patients with Lynch syndrome. This is of particular importance for minority populations, in whom hereditary syndromes are under diagnosed. We compared rates and outcomes of testing all tumor samples (universal testing) collected from a racially and ethnically diverse population for features of Lynch syndrome. METHODS: We performed a retrospective analysis of colorectal tumors tested from 2012 through 2016 at 4 academic centers. Tumor samples were collected from 767 patients with colorectal cancer (52% non-Hispanic white [NHW], 26% African American, and 17% Hispanic patients). We assessed rates of tumor testing, recommendations for genetic evaluation, rates of attending a genetic evaluation, and performance of germline testing overall and by race/ethnicity. We performed univariate and multivariate regression analyses. RESULTS: Overall, 92% of colorectal tumors were analyzed for mismatch repair deficiency without significant differences among races/ethnicities. However, minority patients were significantly less likely to be referred for genetic evaluation (21.2% for NHW patients vs 16.9% for African American patients and 10.9% for Hispanic patients; P = .02). Rates of genetic testing were also lower among minority patients (10.7% for NHW patients vs 6.0% for AA patients and 3.1% for Hispanic patients; P < .01). On multivariate analysis, African American race, older age, and medical center were independently associated with lack of referral for genetic evaluation and genetic testing. CONCLUSION: In a retrospective analysis, we found that despite similar rates of colorectal tumor analysis, minority patients are less likely to be recommended for genetic evaluation or to undergo germline testing for Lynch syndrome. Improvements in institutional practices in follow up after tumor testing could reduce barriers to diagnosis of Lynch diagnosis in minorities.
引用
- Muller C, Lee SM, Barge W, et al. Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2018. PMID: 30130624. doi:10.1016/j.cgh.2018.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。